Abstract:Objective To investigate the etiology composition of enterovirus (EV) in patients with severe hand, foot, and mouth disease (HFMD) in children. To assess the diagnostic value of cerebrospinal fluid (CSF) tests in severe HFMD, and to find the key laboratory tests for severe HFMD. Methods A total of 288 hospitalized cases of children clinically diagnosed with severe HFMD in Hangzhou Children′s Hospital were included from March to July 2016. Throat swabs were collected and enterovirus nucleic acids were detected by fluorescence quantitative reverse transcription (RT)-PCR. Synchronous CSF and serum samples were collected for EV-A71 and CV-sackievirus A16 (CV-A16)-IgM antibody detection. CSF samples underwent routine and biochemical tests. Normally distributed continuous variables were compared using t test. Non-normal distribution continuous variables were compared using Mann-Whitney U test. Differences between categorical variables were compared with χ2 test. Results The total positive rate of enterovirus nucleic acid EV-A71/CV-A16/EV by fluorescence quantitative RT-PCR in the 288 cases of children clinically diagnosed with HFMD was 83.7% (241/288), including EV-A71 55.2% (159/288), CV-A16 4.9% (14/288) and the other enterovirus 23.6% (68/288). Among the other enterovirus group, there were 29.4% CV-A6 (20/68) , 16.2% CV-A4 (11/68) and CV-A10 10.3% (7/68). The total positive rate of combined serum and CSF detection of EV nucleic acid and EV-A71 and CV-A16 IgM antibody was 98.3% (283/288). EV nucleic acid positive rate was 83.7% (24/288). The positive rates were statistically different (χ2 =37.289, P=0.000). The CSF nucleated cells count in EV-A71 positive subgroup was higher than those in CV-A16 positive subgroup and other enteroviruses subgroup (Z=-4.472 and -9.991, respectively, both P 400 mg/L) rate in EV-A71 positive subgroup was higher than those in CV-A16 positive subgroup and other enteroviruses subgroup (χ2=4.956 and 11.795, respectively, both P<0.05). The CSF nucleated cell counts and positive rates in EV-A71 IgM antibody-positive subgroup were both higher than those in antibody-negative subgroup (both P<0.05). The CSF protein level and elevated proportion in antibody-positive subgroup were both higher than those in antibody-negative subgroup (both P<0.05). The lactate dehydrogenase concentration in antibody-positive subgroup was significantly higher than those in antibody-negative subgroup (P<0.05). The EV-A71 IgM antibody in serum was significantly correlated with the antibody in CSF (r=0.600, P<0.05). Conclusions EV-A71 is still the most important pathogen of severe HFMD in Hangzhou in 2016. Other enterovirus such as CV-A6, CV-A4 increases compared to those in 2014 and 2015. The CSF routine and biochemical tests and the IgM antibody levels can serve as an important indicator for the diagnosis of children with severe HFMD. Key words: Hand, foot and mouth disease; Antibodies; Cerebrospinal fluid

Remaining Challenges for Prevention and Control of Hand, Foot, and Mouth Disease.

Epidemic Characteristics of Pathogen Spectrum and Cerebrospinal Fluid Analysis of Severe Hand , Foot , and Mouth Disease in Hangzhou ,2016

PATHOGEN SPECTRUM ANALYSIS OF HAND, FOOT AND MOUTH DISEASE AND GENETIC ANALYSIS OF THE VP1 REGION OF HUMAN ENTEROVIRUS 71 ISOLATED STRAINS IN HANGZHOU

Analysis of pathogens and clinical characterization of hand, foot and mouth disease in Huzhou city from 2013 to 2014

Molecular Epidemiology of Enterovirus from Children with Herpangina or Hand, Foot, and Mouth Disease in Hangzhou, 2016

Review of hand, foot and mouth disease

Changing Epidemiology of Hand, Foot, and Mouth Disease Causative Agents and Contributing Factors

Coxsackievirus B: the important agent of hand, foot, and mouth disease

A review of enterovirus-associated hand-foot and mouth disease: preventive strategies and the need for a global enterovirus surveillance network

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China.

Hand, foot, and mouth disease (HFMD) in India: A review on clinical manifestations, molecular epidemiology, pathogenesis, and prevention

Fourteen Types of Co-Circulating Recombinant Enterovirus Were Associated with Hand, Foot, and Mouth Disease in Children from Wenzhou, China

Genetic Variation of Multiple Serotypes of Enteroviruses Associated with Hand, Foot and Mouth Disease in Southern China

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease

Profiles of Human Enteroviruses Associated with Hand, Foot, and Mouth Disease in Nanjing, China

[Analysis of the Epidemic Characteristics of the Etiological Agents in Children with Hand, Foot and Mouth Disease and Its Clinical Significance].

Hand, Foot and Mouth Disease Caused by Coxsackievirus A6, Beijing, 2013.

Current status of hand-foot-and-mouth disease

Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World

[Epidemiological Investigation of Hand-Foot-and-mouth Disease in Children and Exposed Population in Hangzhou City].

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine